March 4, 2010 (FinancialWire) — Martek Biosciences Corp. (NASDAQ: MATK) said that it has extended a multi-year sole-source license and supply agreement with Danone, a worldwide producer of infant nutrition products.

Under the terms of the amended agreement, Martek will be Danone’s exclusive supplier of ARA for all of its infant formula and growing-up milk products through at least December 31, 2014, which is an extension of Martek’s current exclusive ARA supply position with Danone by three years.

As with the current agreement, Danone may continue to use non-microbial DHA sources. In most cases, Martek said it will continue to serve as Danone’s global supplier for its microbially-derived DHA needs for infant formula.

This is an amendment to a 2007 agreement between Martek and Numico and contains certain limited termination rights. Martek has supplied DHA and ARA to Numico, which was acquired by Danone in 2008, for infant formula products since 1994.

Maryland-based Martek Biosciences is engaged in the development of DHA and ARA and has developed patented technology for the production and use of these ingredients.

The company produces life’sDHA, a vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, perinatal products, and supplements, and life’sARA, a vegetarian source of ARA omega-6, for use in infant formula and growing up milks.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.